News
COCH
3.110
+2.98%
0.090
Envoy Medical’s Stability Threatened: Potential Defaults on Senior Securities May Shake Investor Confidence
TipRanks · 1d ago
Envoy Medical GAAP EPS of -$0.32
Seeking Alpha · 2d ago
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024
Envoy Medical reported earnings per share of -32 cents for the first quarter of 2024. The company reported revenue of $59,000. This was 41% worse than the analyst estimate for revenue in the same period. Envoy Medical also reported results for the second quarter of 2016.
Investorplace · 2d ago
Envoy Medical, Inc. Form 10-Q Quarterly Report: Financial Statements and Other Information
Press release · 2d ago
Envoy Medical Q1 2024 GAAP EPS $(0.32), Sales $59.00K Miss $100.00K Estimate
Benzinga · 2d ago
*Envoy Medical 1Q Loss/Shr 32c >COCH
Dow Jones · 2d ago
*Envoy Medical 1Q Rev $59,000 >COCH
Dow Jones · 2d ago
ENVOY MEDICAL REPORTS FIRST QUARTER 2024 RESULTS
Reuters · 2d ago
Press Release: Envoy Medical Reports First -2-
Forward-looking statements are not guarantees of future performance. If risks materialize or Envoy Medical's assumptions prove incorrect, actual results could differ from the results implied by these forward-looking Statements. The company's balance sheet includes assets and liabilities as of March 31, 2018.
Dow Jones · 2d ago
Press Release: Envoy Medical Reports First Quarter 2024 Results
Envoy Medical Reports First Quarter 2024 Results. Revenue was $59 thousand compared to $78 thousand for the same period in 2017. The Company is a leader in fully implanted hearing devices. Envoy Medical plans to begin its fully implanted cochlear implant clinical trial later in 2024.
Dow Jones · 2d ago
Press Release: Envoy Medical Reports First -3-
Accounts receivable, net: Cash used in operating activities and investing activities. Cash flows from financing activities: Proceeds from the issuance of a loan and cash flows from the sale of property and equipment. Accounts payable: Accounts receivable and other liabilities. Total receivables: $5,846,000. Total liabilities: 1,018.
Dow Jones · 2d ago
Weekly Report: what happened at COCH last week (0506-0510)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Repare Therapeutics (NASDAQ:RPTX) shares rose 34.1% to $4.4 during Wednesday's pre-market session. The company's, Q1 earnings came out yesterday. CEL-SCI stock increased by 13.1%. Myriad Genetics and Envoy Medical also moved upwards.
Benzinga · 05/08 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
FibroGen shares rose 37.1% to $1.59 during Tuesday's pre-market session. The company's, Q1 earnings came out yesterday. Envoy Medical (NASDAQ:COCH) shares moved upwards by 23.54%. ISpecimen shares rose 21.18%.
Benzinga · 05/07 12:06
Weekly Report: what happened at COCH last week (0429-0503)?
Weekly Report · 05/06 12:20
Weekly Report: what happened at COCH last week (0422-0426)?
Weekly Report · 04/29 12:29
Weekly Report: what happened at COCH last week (0415-0419)?
Weekly Report · 04/22 12:12
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. The company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome. Soligenix, Inc. Shares surged 71.5% after the company was granted orphan drug designation for MarVax.
Benzinga · 04/15 18:11
Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals among healthcare movers
Healthcare On the Move Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector +0.99% to 1634.94. Health Care Equipment & Services +1.15% to 1905.2.
Seeking Alpha · 04/15 14:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Soligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Cartesian Therapeutics and Longeveron also moved upwards. Losers Marinus Pharma and PaxMedica stock decreased by more than 20%.
Benzinga · 04/15 12:07
More
Webull provides a variety of real-time COCH stock news. You can receive the latest news about Envoy Medical through multiple platforms. This information may help you make smarter investment decisions.
About COCH
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.